BiG News for MS: 3rd oral disease modifying drug gains FDA Approval

Breaking News:

Tecfidera (BG00012) is FDA approved for relapsing forms of MS

In 1992 we had 0 medications FDA approved for the reduction of relapses and/or disability. Since the Betaseron/Betaferon (Interferon beta-1b under the skin every other day) lottery in 1993, Tecfidera (dimethyl fumarate) becomes the 10th branded MS disease modifying agent approved for use by the FDA (U.S. Food and Drug Administration) and 3rd oral MS DMA/DMD/DMT (disease modifying agent/drug/therapy).

Tecfidera (BG12) is taken orally twice a day to try to prevent MS relapses and disability. Like every medication, it is not right for everyone.

If you are interested in Tecfidera or any of the MS DMDs (Aubagio, Avonex, Betaseron, Copaxone, Extavia, Gilenya, Novantrone, Rebif, Tysabri), talk to your neurologist.
 
- Dr. Daniel Kantor, MD
  Medical Director
  Neurologique

  info@neurologique.org
  www.neurologique.org